JLP:Jubilee Metals had another bad week, dropping 8% in some of my holdings and reducing the gains this week.
PBX:Probiotix Health fell another 5% in my main holding and 13% in my recent holding and didn't bounce back like OPTI:Optibiotix did.
There was some good news, with some shares that were hammered last week recovering a bit.
GAW:Games Workshop went up 5% and are now 13% in profit.
III:3i Group recovered most of last week's loss to go up 5% and are now 19% in profit.
IES:Invinity Energy have been on a bit of a run after being tipped, and climbed 5% this week but are still 79% down.
Share of the week is ASHM:Ashmore Group which climbed 6% to remove most of last week's loss, but are still 25% down.
Here's the ISA and shares portfolio after week 48 of year 8.
Weekly Change | |||
Cash | £239.63 | +£0 | |
Portfolio cost | £87,354.57 | +£0 | |
Portfolio sell value (bid price-commission) |
£22,042.81 | (-74.8%) | +£330.04 |
Potential profits | £137.82 | -£0.70 | |
Yr 8 Dividends | £120.17 | +£0 | |
Yr 8 Interest | £1.51 | +£0 | |
Yr 8 Profit from sales | -£10,795.53 | +£0 | |
Yr 8 proj avg monthly profit | -£967.76 | (-19.6%) | +£20.59 |
Total Dividends | £11,889.09 | +£0 | |
Total Interest | £1.51 | +£0 | |
Total Profit from sales | £17,298.53 | +£0 | |
Average monthly cash profit | £303.09 | (6.2%) | -£0.74 |
(Sold stocks profit + Dividends - Fees / Months) |
|||
Compound performance | 49% | +0% |
Not much happened. Portfolio rise of £330 is a bit feeble given OPTI:Optibiotix went up by over £1,000.
We've been above the tend line for quite a while now, but steadfastly running in parallel.
The SIPP looks like this after week 396 overall and week 32 of year 8.
Weekly Change | ||||
Cash | £411.14 | +£0 | ||
Portfolio cost | £94,850.98 | +£0 | ||
Portfolio sell value (bid price - commission) | £27,617.53 | (-70.9%) | +£321.14 | |
Potential profits | £416.80 | +£49.29 | ||
Yr 8 Dividends | £220.93 | +£0 | ||
Yr 8 Interest | £2.61 | +£0 | ||
Yr 8 Profit from sales | -£9,820.16 | +£0 | ||
Yr 8 proj avg monthly profit | -£1,310.21 | (-24.3%) | +£42.27 | |
Total Dividends | £14,363.71 | +£0 | ||
Total Interest | £2.86 | +£0 | ||
Total Profit from sales | £10,613.59 | +£0 | ||
Average monthly cash profit | £261.59 | (4.8%) | -£0.66 | |
(Sold stocks profit + Dividends - Fees / Months) | ||||
Compound performance | 37% | +0% |
Almost the same as the ISA, climbing by just £321 but at least adding £49 to potential profits.
Nothing to see here.
The trading account looks like this after week 362 overall and week 50 of year 7.
Weekly Change | |||
Cash | £20.26 | +£0 | |
Portfolio cost | £1,763.50 | +£0 | |
Portfolio sell value (bid price - commission) | £909.58 | (-48.4%) | -£19.81 |
Potential profits | £0 | +£0 | |
Year 7 Dividends | £0.00 | +£0 | |
Year 7 Interests | £0.03 | +£0 | |
Year 7 Profit | -£1,157.99 | +£0 | |
Yr 7 proj avg monthly profit | -£100.30 | (-68.2%) | +£2.05 |
Dividends | £60.10 | +£0 | |
Interest | £0.03 | +£0 | |
Profit from sales | -£930.69 | +£0 | |
Average monthly cash profit | -£10.42 | (-7.1%) | +£0.03 |
(Sold stocks profit + Dividends - Fees / Months) |
The rise in OPTI:Optibiotix wasn't enough to counteract the drop in JLP:Jubilee Metals, so this account drops yet again by £19.
Grim
I'm hoping the recovery in OPTI:Optibiotix after results means that people who have sold out are starting to buy back in. Getting up from these desperately low prices is my only hope of being able to report a less dreadful performance. I think I need to face the fact that the share price isn't going to go anywhere until a big Sweetbiotix deal is announced. My worry is, if Sweetbiotix is so great and global corporates are working with us, why are none of them investing in the company or trying to buy us out? I'd be worried about relying on a penny share company with virtually no assets to provide a key ingredient of my global brand. I'm starting to think my early retirement plans are not going to happen, in fact I may not get to retire at all.
No comments:
Post a Comment